Immunoglobulin heavy constant gamma 1 structure
P01857
IGHG1_HUMAN
IGHG1

Immunoglobulin heavy constant gamma 1

免疫球蛋白重常数 γ 1

Homo sapiensTaxon: 9606

3D-structureAdaptive immunityAlternative splicingCell membraneChromosomal rearrangementDirect protein sequencingDisulfide bondGlycoproteinImmunityImmunoglobulinImmunoglobulin domainMembrane+5
序列长度

399

氨基酸

分子量

43.9 kDa

理论值

实验结构

50

PDB 条目

相关疾病

1

已记录

功能描述

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed:17576170, PubMed:20176268, PubMed:22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed:17576170, PubMed:20176268, PubMed:22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed:17576170, PubMed:20176268, PubMed:22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses
免疫球蛋白 (Ig) 重链恒定区。 Igs 是 B 淋巴细胞产生的膜结合或分泌糖蛋白。 在体液免疫的识别阶段,膜结合的 Ig 作为受体,与特定抗原结合后触发 B 淋巴细胞克隆扩增并分化为分泌 Ig 的浆细胞。 分泌的 Igs(称为抗体)通过阻断感染性抗原与细胞受体的相互作用(通过抗原结合区)并引发导致病原体中和的效应机制(通过恒定区)来介导体液免疫的效应器阶段 (PubMed:17576170、PubMed:20176268、PubMed:22158414)。 抗原结合区由一条重链的可变结构域与其相关轻链的可变结构域配对形成。 每个 Ig 分子都有两个抗原结合位点,由于 V-(D)-J 重排、体细胞超突变和抗原暴露后可变域的亲和力成熟,对特定抗原具有显着的亲和力 (PubMed:17576170、PubMed:20176268、PubMed:22158414)。 恒定区定义了执行不同组效应器功能的 Ig 同种型。 B 细胞通过类别转换重组使其 Ig 恒定区多样化并重新排列,这是恒定区从一种 Ig 同种型转换为另一种同种型的过程,即从 IgM 和 IgD 转换为 IgG、IgA 和 IgE (PubMed:17576170、PubMed:20176268、PubMed:22158414)。 Ig gamma-1 (IgG1) 同种型的恒定区(通过可结晶片段 Fc)与先天免疫细胞和补体系统上的受体相互作用,介导体液效应功能,包括抗体依赖性细胞毒性或吞噬作用、补体依赖性细胞毒性和炎症反应
您所阅读的中文介绍为AI翻译机制自动翻译,并未经过人工审核,如有错漏,请以英文原文为准!

相关疾病

Multiple myeloma

A malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia.

氨基酸序列

ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGG
PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYN
STYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDE

FASTA 格式 · 399 个氨基酸 · 分子量 43.9 kDa